Eddie Wehri

Identification of UCB-9721 as a potent inhibitor of MyoA, the essential class XIV myosin motor of apicomplexan parasites

Anne K Snyder, Filomena Tedesco, Anne Kelsen, Eddie Wehri et autres

Abstract The virulence of Toxoplasma gondii and other apicomplexan parasites relies on a unique form of cellular motility driven by MyoA, an unconventional class XIV myosin motor protein. To identify new chemical probes for investigating the molecular mechanisms of parasite motility, we …

us, gb, ca (code pays fourni par la source)

Localized heme sensing through a ternary molecular glue

Michael Heider, Clara Hipp, Zhi Yang, Han Xiao et autres

Molecular glues are an emerging class of therapeutics that stabilize binary interactions and thereby rewire disease-relevant protein networks. Whether glues can integrate additional information to orchestrate signaling beyond initial complex formation is unknown. Here, we report that cells use an endogenous glue …

us, at, in (code pays fourni par la source)

Author response for "Identification of acrylamide-based covalent inhibitors of SARS-CoV-2 (SCoV-2) Nsp15 using high-throughput screening and machine learning"

Teena Bajaj, Babak Mosavati, Lydia H. Zhang, Mohammad S. Parsa et autres

Identification of acrylamide-based covalent inhibitors of SARS-CoV-2 (SCoV-2) Nsp15 using high-throughput screening and machine learning

Teena Bajaj, Babak Mosavati, Lydia H. Zhang, Mohammad S. Parsa et autres

<3, zero violations to Lipinski's rules, and no apparent pan-assay interference (PAINs) properties. In addition, based on this data as a training set, we developed an artificial intelligence (AI) model that accelerated the hit to lead process and had a 73% accuracy …

us, ca (code pays fourni par la source)

Correction: Identification of acrylamide-based covalent inhibitors of SARS-CoV-2 (SCoV-2) Nsp15 using high-throughput screening and machine learning

Teena Bajaj, Babak Mosavati, Lydia H. Zhang, Mohammad S. Parsa et autres

Correction for ‘Identification of acrylamide-based covalent inhibitors of SARS-CoV-2 (SCoV-2) Nsp15 using high-throughput screening and machine learning’ by Teena Bajaj et al. , RSC Adv. , 2025, 15 , 10243–10256, https://doi.org/10.1039/D4RA06955B.

us, ca (code pays fourni par la source)

Author response for "Identification of acrylamide-based covalent inhibitors of SARS-CoV-2 (SCoV-2) Nsp15 using high-throughput screening and machine learning"

Teena Bajaj, Babak Mosavati, Lydia H. Zhang, Mohammad S. Parsa et autres

Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy

James J. Hartman, Darren T. Hwee, Julien Robert‐Paganin, Chih-Yuan Chuang et autres

Hypertrophic cardiomyopathy (HCM) is an inherited disease of the sarcomere resulting in excessive cardiac contractility. The first-in-class cardiac myosin inhibitor, mavacamten, improves symptoms in obstructive HCM. Here we present aficamten, a selective small-molecule inhibitor of cardiac myosin that diminishes ATPase activity by …

us, fr (code pays fourni par la source)

Mechanism of small molecule inhibition of Plasmodium falciparum myosin A informs antimalarial drug design

Dihia Moussaoui, James P. Robblee, Julien Robert‐Paganin, Daniel Auguin et autres

Malaria results in more than 500,000 deaths per year and the causative Plasmodium parasites continue to develop resistance to all known agents, including different antimalarial combinations. The class XIV myosin motor PfMyoA is part of a core macromolecular complex called the glideosome, …

fr, us, gb, au (code pays fourni par la source)

Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis

Joseph M. Hendricks, Cody E. Doubravsky, Eddie Wehri, Zhipeng Li et autres

us, es (code pays fourni par la source)

MyosinA is a druggable target in the widespread protozoan parasite Toxoplasma gondii

Anne Kelsen, Robyn S. Kent, Anne K Snyder, Eddie Wehri et autres

Toxoplasma gondii is a widespread apicomplexan parasite that can cause severe disease in its human hosts. The ability of T. gondii and other apicomplexan parasites to invade into, egress from, and move between cells of the hosts they infect is critical to …

us, gb, ca (code pays fourni par la source)

Author Reply to Peer Reviews of The class XIV myosin of Toxoplasma gondii, TgMyoA, is druggable in an animal model of infection

Anne Kelsen, Robyn S. Kent, Anne K Snyder, Eddie Wehri et autres

us, gb, ca (code pays fourni par la source)

Mercapto-pyrimidines are reversible covalent inhibitors of the papain-like protease (PLpro) and inhibit SARS-CoV-2 (SCoV-2) replication

Teena Bajaj, Eddie Wehri, Rahul K. Suryawanshi, Elizabeth A. King et autres

0.85 μM, 6-fold higher). Activity based profiling of compound 5 demonstrated that it reacts with PLpro cysteines. We show here that compound 5 represents a new class of RCIs, which undergo an addition elimination reaction with cysteines in their target proteins. We …

us (code pays fourni par la source)